This is a Validated Antibody Database (VAD) review about human SLC39A14, based on 3 published articles (read how Labome selects the articles), using SLC39A14 antibody in all methods. It is aimed to help Labome visitors find the most suited SLC39A14 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
SLC39A14 synonym: HMNDYT2; LZT-Hs4; NET34; ZIP14; cig19; zinc transporter ZIP14; LIV-1 subfamily of ZIP zinc transporter 4; Zrt-, Irt-like protein 14; solute carrier family 39 (metal ion transporter), member 14; solute carrier family 39 (zinc transporter), member 14; zrt- and Irt-like protein 14

Invitrogen
rabbit polyclonal
  • western blot; mouse; fig 2c
In order to measure the expression of three ferrous iron importers, Dmt1, Zip8, and Zip14 in retinas, Invitrogen SLC39A14 antibody (ThermoScientific, PA5-21077) was used in western blot on mouse samples (fig 2c). Exp Eye Res (2017) ncbi
Abcam
rabbit polyclonal
  • western blot; human; 1:2000; loading ...
In order to find the specific gene signature related to iron metabolism consisting of genes regulating iron uptake, mitochondrial FeS cluster biogenesis and hypoxic response, Abcam SLC39A14 antibody (Abcam, ab191199) was used in western blot on human samples at 1:2000. Oncotarget (2017) ncbi
ProSci
rabbit polyclonal
  • western blot; human; fig 3
ProSci SLC39A14 antibody (ProSci, 6105) was used in western blot on human samples (fig 3). Onco Targets Ther (2016) ncbi
Articles Reviewed
  1. Sterling J, Guttha S, Song Y, Song D, Hadziahmetovic M, Dunaief J. Iron importers Zip8 and Zip14 are expressed in retina and regulated by retinal iron levels. Exp Eye Res. 2017;155:15-23 pubmed publisher
  2. Rychtarčíková Z, Lettlova S, Tomkova V, Korenkova V, Langerova L, Simonova E, et al. Tumor-initiating cells of breast and prostate origin show alterations in the expression of genes related to iron metabolism. Oncotarget. 2017;8:6376-6398 pubmed publisher
  3. Xu X, Wang C, Zhu Y, Chen W, Shao S, Jiang F, et al. Decreased expression of SLC 39A14 is associated with tumor aggressiveness and biochemical recurrence of human prostate cancer. Onco Targets Ther. 2016;9:4197-205 pubmed publisher